If all humans—regardless of their race—are so genetically similar, why is it important that clinical trials are racially diverse? In this video, we explore this question and what it means for promoting health equity.
Boyle, P. (2021, August 20). Clinical trials seek to fix their lack of racial mix. Association of American Medical Colleges. https://www.aamc.org/news-insights/clinical-trials-seek-fix-their-lack-racial-mix Gray, D. M., Nolan, T. S., Gregory, J., & Joseph, J. J. (2021, August). Diversity in clinical trials: An opportunity and imperative for community engagement. The Lancet Gastroenterology and Hepatology, 6(8), 605–607. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00228-4/fulltext National Institute on Aging (n.d.) What are clinical trials and studies? https://www.nia.nih.gov/health/what-are-clinical-trials-and-studies Okah, E., Thomas, J., Westby, A., & Cunningham, B. (2021, September). Colorblind racial ideology is associated with the use of race in medical decision‐making. Journal of Racial and Ethnic Health Disparities, 9(5), 2019–2026. https://link.springer.com/article/10.1007/s40615-021-01141-1 Singh, G. K., Daus, G. P, Allender, M., Ramey, C. T., Martin, E. K., Perry, C., Reyes, A., & Vedamuthu, I. P. (2017). Social determinants of health in the United States: Addressing major health inequality trends for the nation, 1935–2016. International Journal of Maternal and Child Health and AIDS (IJMA), 6(2). https://doi.org/10.21106/ijma.236